Overall, knocking down the expression of AURKB could suppress both vemurafenib-sensitive and -resistant melanoma cell growth and induce apoptosis through the mediation of the BRAF/MEK/ERKs and PI3-K/AKT pathways. The gene discussed is MAP2K7; the disease is melanoma.